Perbak Capital Partners LLP Incyte Corp Transaction History
Perbak Capital Partners LLP
- $568 Billion
- Q3 2025
A detailed history of Perbak Capital Partners LLP transactions in Incyte Corp stock. As of the latest transaction made, Perbak Capital Partners LLP holds 5,298 shares of INCY stock, worth $551,786. This represents 0.08% of its overall portfolio holdings.
Number of Shares
5,298
Previous 5,169
2.5%
Holding current value
$551,786
Previous $352 Million
27.65%
% of portfolio
0.08%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding INCY
# of Institutions
795Shares Held
205MCall Options Held
638KPut Options Held
635K-
Baker Bros. Advisors LP New York, NY30.7MShares$3.2 Billion21.24% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$2.22 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$2.08 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$1.45 Billion0.68% of portfolio
-
State Street Corp Boston, MA9.68MShares$1.01 Billion0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $23.2B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...